Status:
RECRUITING
ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer Rosettes
Lead Sponsor:
Hackensack Meridian Health
Conditions:
Embryonal Tumor With Multilayered Rosettes
Eligibility:
All Genders
Brief Summary
This research is being done to find out more information about a brain tumor called Embryonal Tumor with Multilayer Rosettes (ETMR) by collecting medical information from children who have this diseas...
Detailed Description
All patients with ETMR are eligible for inclusion within the registry, regardless of their disease status or treatment plan. Epidemiologic, clinical, and molecular data from each patient will be obtai...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients of any age
- Patients must have either a histologically confirmed primary intracranial CNS Embryonal Tumor with Multilayer Rosettes (as agreed upon by central review or local pathologist OR
- Patients must have tumor tissue that possesses C19MC amplification . Central Review is not required (but is strongly recommended) if the patient's tumor does not demonstrate C19MC amplification.
- Patients may be enrolled at point following diagnosis
Exclusion
Key Trial Info
Start Date :
July 12 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 12 2030
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04794686
Start Date
July 12 2020
End Date
July 12 2030
Last Update
June 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hackensack University Medical Center
Hackensack, New Jersey, United States, 07601